tiprankstipranks
Trending News
More News >
Genworth Financial Inc (GNW)
NYSE:GNW
Advertisement

Genworth Financial (GNW) AI Stock Analysis

Compare
711 Followers

Top Page

GNW

Genworth Financial

(NYSE:GNW)

Rating:67Neutral
Price Target:
$9.00
▲(7.02% Upside)
Genworth Financial's overall stock score is driven by strong technical indicators and positive earnings call highlights, including strategic progress and capital returns. However, the score is tempered by financial performance challenges, particularly in revenue growth and cash flow generation. The valuation is moderate, and the lack of a dividend yield limits its appeal to income investors.

Genworth Financial (GNW) vs. SPDR S&P 500 ETF (SPY)

Genworth Financial Business Overview & Revenue Model

Company DescriptionGenworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.
How the Company Makes MoneyGenworth Financial generates revenue primarily through premiums collected from its insurance products, including life insurance and long-term care insurance. The company also earns significant income from mortgage insurance premiums, where it provides coverage to lenders against borrower defaults. Additionally, investment income from the management of its insurance reserves contributes to its earnings. Strategic partnerships with lenders and financial institutions enhance their mortgage insurance segment, while ongoing adjustments to pricing and underwriting practices help maintain profitability. Overall, Genworth's revenue model is anchored in a combination of premium income and investment returns, supported by a focus on risk management and product innovation.

Genworth Financial Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: 6.05%|
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Positive
The earnings call reflects a generally positive sentiment with strong financial performance and strategic progress, including favorable litigation outcomes and successful capital return strategies. However, there are ongoing challenges in the LTC and life insurance segments.
Q2-2025 Updates
Positive Updates
Solid Financial Performance
Genworth reported net income of $51 million and adjusted operating income of $68 million for the quarter, with significant contributions from Enact totaling $141 million.
Strong Liquidity and Capital Returns
The liquidity position remains strong with $248 million in cash and liquid assets. Enact is expected to return approximately $400 million to shareholders in 2025, of which Genworth anticipates receiving $325 million.
Successful Strategic Initiatives
Enact continues to be a key source of cash flow. The launch of CareScout services and expansion of its network to all 50 states is expected to drive fee-based revenue growth.
Favorable Court Judgment
A favorable judgment in the AXA and Santander litigation could result in a recovery of approximately $750 million for Genworth.
Negative Updates
Long-Term Care Insurance Segment Loss
The LTC Insurance segment reported an adjusted operating loss of $37 million, driven by unfavorable actual variances from expected experience, resulting in a remeasurement loss.
Life Insurance Operating Loss
The life insurance segment reported an adjusted operating loss of $20 million despite improvements from the prior quarter due to lower mortality.
Company Guidance
During Genworth Financial's second quarter 2025 earnings call, the company highlighted several key metrics and strategic priorities. Genworth reported a net income of $51 million for the quarter, with adjusted operating income reaching $68 million or $0.16 per share. Enact, a major contributor, added $141 million to adjusted operating income. The U.S. life insurance companies' estimated pretax statutory income was $81 million, bolstered by favorable equity market and interest rate movements. Genworth's liquidity remained strong, ending the quarter with $248 million in cash and liquid assets. Enact announced plans to return approximately $400 million of capital to shareholders in 2025, enhancing shareholder value. Since Enact's IPO in 2021, it has returned over $1 billion in capital to Genworth, supporting share buybacks totaling $630 million at an average price of $5.80. The multiyear rate action program (MYRAP) secured $41 million in gross incremental premium approvals this quarter, with a cumulative net present value of approximately $31.6 billion. CareScout, another focus area, expanded its product offerings and network, aiming for long-term growth and contributing fee-based revenue. The CareScout Quality Network now includes nearly 650 home care providers and covers over 90% of the U.S. age 65-plus population. The network achieved 1,400 successful matches between policyholders and providers this year, with a full-year estimate of 2,850 matches. Additionally, Genworth is launching a new stand-alone LTC insurance product through CareScout Insurance, having secured approvals in 29 jurisdictions. The company also addressed a favorable judgment in the AXA and Santander litigation, expecting to recover approximately $750 million if appeals are resolved favorably. This recovery has not yet been factored into capital allocation plans, which prioritize growth through CareScout, shareholder returns via buybacks, and potential debt reduction.

Genworth Financial Financial Statement Overview

Summary
Genworth Financial faces challenges with declining revenues and profitability, as reflected in its income statement. The balance sheet remains strong with low leverage, but profitability metrics like ROE have weakened. Cash flow generation is a concern, with significant declines in free cash flow growth. Overall, while the company maintains a stable financial position, it needs to address revenue growth and cash flow generation to improve its financial health.
Income Statement
55
Neutral
Genworth Financial's income statement reveals a mixed performance. The company has experienced declining revenue over the past few years, with a negative revenue growth rate of -15.6% in the TTM. Margins have also been under pressure, with the net profit margin decreasing to 2.68% in the TTM from 4.19% in 2024. However, the company maintains a reasonable gross profit margin of 53.4% in the TTM, indicating some operational efficiency.
Balance Sheet
65
Positive
The balance sheet shows a stable financial position with a low debt-to-equity ratio of 0.17 in the TTM, reflecting prudent financial management. However, the return on equity has decreased to 2.20% in the TTM, indicating lower profitability on shareholders' equity. The equity ratio remains healthy, suggesting a solid capital structure.
Cash Flow
50
Neutral
Cash flow analysis indicates challenges, with a significant decline in free cash flow growth of -43.7% in the TTM. The operating cash flow to net income ratio is low, suggesting potential issues in converting income into cash. However, the free cash flow to net income ratio remains strong at 1.0, indicating that the company is generating cash equivalent to its net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.06B7.14B7.49B7.51B7.83B8.66B
Gross Profit3.77B7.14B7.49B7.51B7.83B8.66B
EBITDA803.00M710.00M461.00M1.52B1.39B1.17B
Net Income189.00M299.00M76.00M916.00M850.00M761.00M
Balance Sheet
Total Assets87.34B86.87B90.82B86.44B99.17B105.75B
Cash, Cash Equivalents and Short-Term Investments61.22B7.72B2.21B61.39B74.50B80.57B
Total Debt1.52B1.52B1.58B1.61B1.90B3.55B
Total Liabilities77.56B77.44B82.48B75.70B1.88B3.53B
Stockholders Equity8.79B8.49B7.48B9.98B15.51B15.32B
Cash Flow
Free Cash Flow228.00M88.00M597.00M1.05B437.00M2.23B
Operating Cash Flow228.00M88.00M597.00M1.05B437.00M1.96B
Investing Cash Flow620.00M861.00M1.26B733.00M896.00M-1.15B
Financing Cash Flow-982.00M-1.11B-1.44B-1.55B-2.42B-1.51B

Genworth Financial Technical Analysis

Technical Analysis Sentiment
Positive
Last Price8.41
Price Trends
50DMA
7.79
Positive
100DMA
7.33
Positive
200DMA
7.21
Positive
Market Momentum
MACD
0.22
Negative
RSI
62.11
Neutral
STOCH
61.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GNW, the sentiment is Positive. The current price of 8.41 is above the 20-day moving average (MA) of 8.21, above the 50-day MA of 7.79, and above the 200-day MA of 7.21, indicating a bullish trend. The MACD of 0.22 indicates Negative momentum. The RSI at 62.11 is Neutral, neither overbought nor oversold. The STOCH value of 61.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GNW.

Genworth Financial Risk Analysis

Genworth Financial disclosed 37 risk factors in its most recent earnings report. Genworth Financial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Genworth Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (58)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$4.59B13.938.40%2.55%1.78%0.77%
73
Outperform
$3.68B13.9811.35%1.64%0.82%-29.29%
71
Outperform
$7.69B7.0812.97%4.40%11.33%-38.17%
67
Neutral
$3.46B19.142.42%2.61%465.03%
63
Neutral
$6.67B82.500.30%3.12%27.18%-100.02%
62
Neutral
$2.64B5.0513.53%59.27%
58
Neutral
HK$110.85B6.44-4.87%3.92%9.01%-47.48%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GNW
Genworth Financial
8.41
1.59
23.31%
CNO
CNO Financial
39.62
6.34
19.05%
LNC
Lincoln National
41.94
12.03
40.22%
BHF
Brighthouse Financial
46.42
1.05
2.31%
JXN
Jackson Financial Incorporation
98.47
14.30
16.99%
FG
F&G Annuities & Life Inc
35.33
-5.86
-14.23%

Genworth Financial Corporate Events

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
Genworth Financial Approves Key Governance Changes
Neutral
May 22, 2025

At the 2025 annual meeting held on May 22, Genworth Financial‘s stockholders elected ten directors, approved executive compensation, the 2025 Omnibus Incentive Plan, and the selection of KPMG LLP as the accounting firm. An amendment to remove the ‘Pass-Through Voting’ provision was also approved, indicating strategic governance changes.

The most recent analyst rating on (GNW) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Genworth Financial stock, see the GNW Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 11, 2025